AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
AKYA(Quitar la ciudad)
Akoya Biosciences·NASDAQ
--
--(--)
Akoya Biosciences (AKYA) Financial Statements
Akoya Biosciences (AKYA) Income Statement
During Q3 2024, Akoya Biosciences (AKYA) reported revenue of 18.81M, a YoY change of -25.39%. Net income was -10.53M, a YoY change of 18.45%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 11.02M -- | 8.56M -- | 9.95M -- | 12.91M -- | 12.21M +10.81% | 13.07M +52.70% | 13.48M +35.38% | 16.16M +25.18% | 16.89M +38.34% | 17.89M +36.90% | 18.85M +39.89% | 21.22M +31.32% | 21.41M +26.73% | 23.52M +31.45% | 25.21M +33.75% | 26.49M +24.83% | 18.35M -14.29% | 23.16M -1.52% | 18.81M -25.39% | 86.81M -- |
Sales and Services Revenue | 11.02M -- | 8.56M -- | 9.95M -- | 12.91M -- | 12.21M +10.81% | 13.07M +52.70% | 13.48M +35.38% | 16.16M +25.18% | 16.89M +38.34% | 17.89M +36.90% | 18.85M +39.89% | 21.22M +31.32% | 21.41M +26.73% | 23.52M +31.45% | 25.21M +33.75% | 26.49M +24.83% | 18.35M -14.29% | 23.16M -1.52% | 18.81M -25.39% | 86.81M -- |
Cost of Revenue | 4.33M -- | 3.29M -- | 3.92M -- | 5.00M -- | 4.81M +11.14% | 4.94M +50.06% | 5.02M +28.14% | 5.93M +18.64% | 6.80M +41.42% | 7.55M +52.99% | 7.95M +58.17% | 9.17M +54.64% | 9.12M +34.11% | 11.40M +51.00% | 9.94M +25.10% | 9.87M +7.57% | 9.97M +9.37% | 9.78M -14.27% | 7.09M -28.66% | 36.71M -- |
Gross Profit | 6.70M -- | 5.27M -- | 6.03M -- | 7.91M -- | 7.41M +10.59% | 8.13M +54.35% | 8.45M +40.09% | 10.23M +29.31% | 10.10M +36.34% | 10.34M +27.13% | 10.91M +29.03% | 12.05M +17.80% | 12.29M +21.76% | 12.12M +17.16% | 15.28M +40.06% | 16.62M +37.97% | 8.38M -31.84% | 13.39M +10.48% | 11.72M -23.25% | 50.11M -- |
Operating Expenses | 8.06M -- | 9.10M -- | 9.70M -- | 11.06M -- | 12.81M +58.90% | 14.51M +59.44% | 19.19M +97.84% | 27.01M +144.24% | 25.65M +100.30% | 26.65M +83.63% | 27.56M +43.60% | 29.64M +9.74% | 29.73M +15.90% | 31.36M +17.67% | 26.83M -2.66% | 26.06M -12.07% | 29.96M +0.79% | 24.47M -21.97% | 20.07M -25.18% | 100.57M -- |
Selling, General and Administrative Expenses | 7.25M -- | 6.03M -- | 6.68M -- | 7.84M -- | 9.19M +26.77% | 11.16M +85.25% | 14.97M +123.99% | 20.42M +160.49% | 19.74M +114.80% | 22.21M +98.90% | 21.74M +45.21% | 22.71M +11.20% | 23.12M +17.17% | 23.91M +7.65% | 20.25M -6.84% | 23.17M +2.03% | 19.86M -14.10% | 19.09M -20.13% | 14.67M -27.55% | 76.80M -- |
Research and Development Expenses | 2.37M -- | 2.42M -- | 2.28M -- | 2.53M -- | 3.19M +34.57% | 2.95M +21.78% | 4.00M +75.47% | 5.56M +119.71% | 5.71M +79.01% | 5.60M +89.96% | 5.47M +36.68% | 6.43M +15.64% | 6.38M +11.62% | 6.92M +23.67% | 6.31M +15.51% | 2.27M -64.64% | 5.55M -12.92% | 5.29M -23.62% | 4.47M -29.14% | 17.59M -- |
Other Operating Expenses | -1.56M -- | 655.00K -- | 739.00K -- | 686.00K -- | 426.00K +127.29% | 400.00K -38.93% | 224.00K -69.69% | 1.02M +49.13% | 200.00K -53.05% | -1.16M -389.00% | 357.00K +59.38% | 497.00K -51.42% | 227.00K +13.50% | 530.00K +145.85% | 262.00K -26.61% | 617.00K +24.14% | 4.55M +1903.08% | 88.00K -83.40% | 927.00K +253.82% | 6.18M -- |
Operating Income | -1.36M -- | -3.83M -- | -3.67M -- | -3.15M -- | -5.40M -296.26% | -6.38M -66.44% | -10.74M -192.86% | -16.78M -432.87% | -15.55M -187.98% | -16.31M -155.69% | -16.65M -55.07% | -17.59M -4.83% | -17.44M -12.10% | -19.24M -17.99% | -11.55M +30.64% | -9.44M +46.34% | -21.59M -23.80% | -11.08M +42.40% | -8.35M +27.72% | -50.46M -- |
Non-Operating Income (Loss) | -742.00K -- | -714.00K -- | -626.00K -- | -2.57M -- | -2.69M -262.13% | 809.00K +213.31% | -889.00K -42.01% | -1.01M +60.72% | -823.00K +69.37% | -1.08M -233.62% | -1.20M -34.76% | -1.31M -29.70% | -1.34M -62.45% | -1.54M -42.74% | -1.35M -12.69% | -1.39M -5.73% | -1.84M -37.32% | -2.02M -30.78% | -2.14M -58.52% | -7.38M -- |
Other Non-Operating Income (Loss) | -105.00K -- | -56.00K -- | 57.00K -- | -1.83M -- | -1.94M -1743.81% | 1.57M +2896.43% | -126.00K -321.05% | -166.09K +90.90% | -96.00K +95.04% | -286.00K -118.26% | -225.00K -78.57% | -28.00K +83.14% | -48.00K +50.00% | -105.00K +63.29% | -185.00K +17.78% | -5.00K +82.14% | -161.00K -235.42% | -80.00K +23.81% | -36.00K +80.54% | -282.00K -- |
Net Interest Expense | 637.00K -- | 658.00K -- | 683.00K -- | 745.00K -- | 751.00K +17.90% | 757.00K +15.05% | 763.00K +11.71% | 843.91K +13.28% | 727.00K -3.20% | 795.00K +5.02% | 973.00K +27.52% | 1.28M +51.91% | 1.29M +77.30% | 1.44M +80.88% | 1.17M +19.73% | 1.38M +7.64% | 1.68M +29.95% | 1.94M +34.77% | 2.10M +80.60% | 7.10M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 763.00K -- | 844.00K -- | 749.00K -- | 849.00K -- | 1.11M +45.35% | 1.85M +118.84% | 2.05M +174.23% | 2.17M +156.18% | 2.24M +101.89% | 2.29M +24.15% | 2.61M +27.17% | 2.61M +19.82% | 2.63M +17.24% | 10.14M -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 91 -- | 22.00K -- | 54.00K -- | 136.00K -- | 565.00K +620779.12% | 765.00K +3377.27% | 737.00K +1264.81% | 1.07M +689.71% | 913.00K +61.59% | 937.00K +22.48% | 668.00K -9.36% | 521.00K -51.49% | 3.04M -- |
Pretax Income From Continuing Operations | -2.10M -- | -4.55M -- | -4.29M -- | -5.72M -- | -8.09M -284.23% | -5.57M -22.50% | -11.63M -170.86% | -17.79M -211.01% | -16.38M -102.49% | -17.39M -212.25% | -17.85M -53.52% | -18.90M -6.25% | -18.77M -14.63% | -20.79M -19.53% | -12.90M +27.73% | -10.82M +42.73% | -23.42M -24.76% | -13.10M +36.96% | -10.49M +18.70% | -57.84M -- |
Income Tax Expense | 38.00K -- | 39.00K -- | -9.00K -- | -26.00K -- | -6.00K -115.79% | -6.00K -115.38% | -11.00K -22.22% | -117.00K -350.00% | 22.00K +466.67% | 106.00K +1866.67% | 21.00K +290.91% | -26.00K +77.78% | 29.00K +31.82% | 18.00K -83.02% | 15.00K -28.57% | -22.00K +15.38% | 63.00K +117.24% | 47.00K +161.11% | 44.00K +193.33% | 132.00K -- |
Net Income from Continuing Operations | -2.14M -- | -4.58M -- | -4.28M -- | -5.69M -- | -8.08M -277.13% | -5.56M -21.33% | -11.62M -171.17% | -17.67M -210.38% | -16.40M -102.91% | -17.50M -214.49% | -17.87M -53.84% | -18.88M -6.80% | -18.80M -14.65% | -20.80M -18.91% | -12.92M +27.73% | -10.80M +42.77% | -23.48M -24.90% | -13.15M +36.79% | -10.53M +18.45% | -57.97M -- |
Net Income | -2.14M -- | -4.58M -- | -4.28M -- | -5.69M -- | -8.08M -277.13% | -5.56M -21.33% | -11.62M -171.17% | -17.67M -210.38% | -16.40M -102.91% | -17.50M -214.49% | -17.87M -53.84% | -18.88M -6.80% | -18.80M -14.65% | -20.80M -18.91% | -12.92M +27.73% | -10.80M +42.77% | -23.48M -24.90% | -13.15M +36.79% | -10.53M +18.45% | -57.97M -- |
Net Income Attributable to Owners of the Company | -2.14M -- | -4.58M -- | -4.28M -- | -5.69M -- | -8.08M -277.13% | -5.56M -21.33% | -11.62M -171.17% | -17.67M -210.38% | -16.40M -102.91% | -17.50M -214.49% | -17.87M -53.84% | -18.88M -6.80% | -18.80M -14.65% | -20.80M -18.91% | -12.92M +27.73% | -10.80M +42.77% | -23.48M -24.90% | -13.15M +36.79% | -10.53M +18.45% | -57.97M -- |
Preferred Stock Dividends | -- -- | 1.49M -- | 1.49M -- | 1.19M -- | 1.49M -- | 541.00K -63.59% | -- -- | -296.00K -124.87% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -2.14M -- | -6.07M -- | -5.77M -- | -6.88M -- | -9.57M -346.48% | -6.10M -0.54% | -11.62M -101.33% | -17.38M -152.43% | -16.40M -71.39% | -17.50M -186.62% | -17.87M -53.84% | -18.88M -8.62% | -18.80M -14.65% | -20.80M -18.91% | -12.92M +27.73% | -10.80M +42.77% | -23.48M -24.90% | -13.15M +36.79% | -10.53M +18.45% | -57.97M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -92.00K -- | 26.00K -- | 60.00K -- | 6.00K -- | -- -- | -- -- | 0 -100.00% | -16.00K -366.67% | 4.00K -- | 20.00K -- | 8.00K -- |
Total Comprehensive Income | -- -- | -- -- | -- -- | -- -- | -- -- | -5.56M -- | -11.62M -- | -17.67M -- | -16.40M -- | -17.59M -216.14% | -17.85M -53.62% | -18.82M -6.46% | -18.80M -14.62% | -20.80M -18.29% | -12.92M +27.63% | -10.80M +42.59% | -23.50M -25.03% | -13.14M +36.81% | -10.51M +18.60% | -57.96M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -- -- | -5.56M -- | -11.62M -- | -17.67M -- | -16.40M -- | -17.59M -216.14% | -17.85M -53.62% | -18.82M -6.46% | -18.80M -14.62% | -20.80M -18.29% | -12.92M +27.63% | -10.80M +42.59% | -23.50M -25.03% | -13.14M +36.81% | -10.51M +18.60% | -57.96M -- |
Basic EPS | -1.59 -- | -2.65 -- | -2.44 -- | -- -- | -3.54 -122.64% | -0.2 +92.45% | -0.31 +87.30% | -- -- | -0.44 +87.57% | -0.47 -135.00% | -0.47 -51.61% | -- -- | -0.49 -11.36% | -0.51 -8.51% | -0.26 +44.68% | -- -- | -0.48 +2.04% | -0.27 +47.06% | -0.21 +19.23% | -- -- |
Diluted EPS | -1.59 -- | -2.65 -- | -2.44 -- | -- -- | -3.54 -122.64% | -0.2 +92.45% | -0.31 +87.30% | -- -- | -0.44 +87.57% | -0.47 -135.00% | -0.47 -51.61% | -- -- | -0.49 -11.36% | -0.51 -8.51% | -0.26 +44.68% | -- -- | -0.48 +2.04% | -0.27 +47.06% | -0.21 +19.23% | -- -- |
You can ask Aime
No Data
